Hybrid Closed-Loop Insulin Improves Glycemic Control in T1D-Complicated Pregnancy
FRIDAY, Oct. 6, 2023 (HealthDay News) — For pregnant women with type 1 diabetes, hybrid closed-loop insulin therapy significantly improves maternal glycemic control, according to a study published online Oct. 5 in the New England Journal of Medicine …
Learn MorePrevalence of Hearing Loss Significantly Higher for Cancer Survivors
FRIDAY, Oct. 6, 2023 (HealthDay News) — Cancer survivors have a significantly higher prevalence of hearing loss (HL) than the general population, according to a study published online Oct. 5 in JAMA Otolaryngology-Head and Neck Surgery.Qian Wang, M.D…
Learn MoreReductions Seen in HbA1c, Body Weight With Once-Weekly Tirzepatide
FRIDAY, Oct. 6, 2023 (HealthDay News) — For patients with inadequately controlled type 2 diabetes, once-weekly subcutaneous injections of tirzepatide yield reductions in hemoglobin A1c (HbA1c) and body weight compared with insulin lispro, according t…
Learn MoreDiabetes More Prevalent in Black Patients With Multiple Myeloma
FRIDAY, Oct. 6, 2023 (HealthDay News) — Diabetes mellitus (DM) is more prevalent among Black patients with multiple myeloma (MM) and is associated with overall survival in MM, especially among White patients, according to a study published online Sep…
Learn MoreEfgartigimod Efficacious, Safe for Primary Immune Thrombocytopenia
FRIDAY, Oct. 6, 2023 (HealthDay News) — The first-in-class novel human immunoglobulin G1 Fc fragment, efgartigimod, is efficacious and safe for patients with chronic or persistent primary immune thrombocytopenia, according to a study published online…
Learn MoreNCCN: Cancer Centers Still Experiencing Shortages of Chemo Drugs
THURSDAY, Oct. 5, 2023 (HealthDay News) — Many cancer centers are still experiencing a shortage of carboplatin, cisplatin, and other chemotherapy drugs, according to the results of a follow-up survey conducted Sept. 6 to 20, 2023, by the National Com…
Learn MorePediatric Case Fatality Rates Increased From 2011 to 2021
THURSDAY, Oct. 5, 2023 (HealthDay News) — Pediatric case fatality rates have increased over the past decade, driven by a reduction in nonfatal injuries and increasing fatal injuries, according to a research brief published online Oct. 5 in Pediatrics…
Learn MorePediatric Case Fatality Rates Increased From 2011 to 2021
THURSDAY, Oct. 5, 2023 (HealthDay News) — Pediatric case fatality rates have increased over the past decade, driven by a reduction in nonfatal injuries and increasing fatal injuries, according to a research brief published online Oct. 5 in Pediatrics…
Learn MoreEsketamine Nasal Spray Beneficial for Treatment-Resistant Depression
THURSDAY, Oct. 5, 2023 (HealthDay News) — For patients with treatment-resistant depression, esketamine nasal spray is superior to extended-release quetiapine with respect to remission at week 8, according to a study published in the Oct. 5 issue of t…
Learn MoreEsketamine Nasal Spray Beneficial for Treatment-Resistant Depression
THURSDAY, Oct. 5, 2023 (HealthDay News) — For patients with treatment-resistant depression, esketamine nasal spray is superior to extended-release quetiapine with respect to remission at week 8, according to a study published in the Oct. 5 issue of t…
Learn More